Cargando…

Effects of Testosterone Replacement Therapy on Glycolipid Metabolism Among Hypogonadal Men withT2DM: A Meta-Analysis And System Review Of Randomized Controlled Trials

INTRODUCTION: Testosterone can improve glucose metabolism through multiple cellular mechanisms. However, it remains unclear as to whether hypogonadal men with type 2 diabetes mellitus (T2DM) can benefit from testosterone replacement therapy (TRT). AIMS: To assess the relative effect of TRT on glycol...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Xiaowei, Wei, Zhentong, Liu, Yanhong, Zhang, XiaoYuan, Wang, Qun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360908/
https://www.ncbi.nlm.nih.gov/pubmed/34298329
http://dx.doi.org/10.1016/j.esxm.2021.100403
_version_ 1783737843449856000
author Yu, Xiaowei
Wei, Zhentong
Liu, Yanhong
Zhang, XiaoYuan
Wang, Qun
author_facet Yu, Xiaowei
Wei, Zhentong
Liu, Yanhong
Zhang, XiaoYuan
Wang, Qun
author_sort Yu, Xiaowei
collection PubMed
description INTRODUCTION: Testosterone can improve glucose metabolism through multiple cellular mechanisms. However, it remains unclear as to whether hypogonadal men with type 2 diabetes mellitus (T2DM) can benefit from testosterone replacement therapy (TRT). AIMS: To assess the relative effect of TRT on glycolipid metabolism among hypogonadal men with T2DM. METHODS: : Electronic literature searches of the Cochrane Library, PubMed, MEDLINE, and EMBASE databases were conducted, up to the end of October 2020. Only studies that used randomized controlled trials (RCTs) were included in our systematic review. Main outcome measures From these studies, we extracted certain outcomes including changes in insulin resistance, glucose metabolism, and lipid parameters. RESULTS: There were a total of 8 studies that met our criteria. Four of these studies either did not have a consistent treatment strategy, or the control groups used untreated patients rather than patients that had been given a placebo. Thus, results from these four studies contributed to the variability in treatment outcomes. In four of the examined RCTs, there was no change in either the dose or the type of antidiabetic medication prescribed. Based on the homeostatic model assessment of insulin resistance, the pooled WMD was −0.34, 95% confidence interval (CI; −1.02, 0.34), P = .33; For fasting plasma glucose, the pooled WMD was −0.27, 95% CI (−1.02, 0.48), P = .48, the pooled WMD for HbA1c% was −0.00, 95% CI (−1.08, 1.08), P = 1.00. CONCLUSIONS: Although certain RCTs showed that TRT improved insulin resistance and glycolipid metabolism when compared with the placebo or untreated control groups, these findings may partly be due to changes in antidiabetic therapy during the course of the study. In the current meta-analysis, analyses showed that TRT did not significantly improve insulin resistance or glycolipid metabolism. Future studies need to be rigorous in design and delivery, and comprehensive descriptions of all aspects of their methods should be included to further enable a more accurate appraisal and interpretation of the results. Yu X, Wei Z, Liu Y, et al. Effects of Testosterone Replacement Therapy on Glycolipid Metabolism Among Hypogonadal Men with T2DM: A Meta-Analysis And System Review Of Randomized Controlled Trials. Sex Med 2021;9:100403.
format Online
Article
Text
id pubmed-8360908
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-83609082021-08-17 Effects of Testosterone Replacement Therapy on Glycolipid Metabolism Among Hypogonadal Men withT2DM: A Meta-Analysis And System Review Of Randomized Controlled Trials Yu, Xiaowei Wei, Zhentong Liu, Yanhong Zhang, XiaoYuan Wang, Qun Sex Med Review INTRODUCTION: Testosterone can improve glucose metabolism through multiple cellular mechanisms. However, it remains unclear as to whether hypogonadal men with type 2 diabetes mellitus (T2DM) can benefit from testosterone replacement therapy (TRT). AIMS: To assess the relative effect of TRT on glycolipid metabolism among hypogonadal men with T2DM. METHODS: : Electronic literature searches of the Cochrane Library, PubMed, MEDLINE, and EMBASE databases were conducted, up to the end of October 2020. Only studies that used randomized controlled trials (RCTs) were included in our systematic review. Main outcome measures From these studies, we extracted certain outcomes including changes in insulin resistance, glucose metabolism, and lipid parameters. RESULTS: There were a total of 8 studies that met our criteria. Four of these studies either did not have a consistent treatment strategy, or the control groups used untreated patients rather than patients that had been given a placebo. Thus, results from these four studies contributed to the variability in treatment outcomes. In four of the examined RCTs, there was no change in either the dose or the type of antidiabetic medication prescribed. Based on the homeostatic model assessment of insulin resistance, the pooled WMD was −0.34, 95% confidence interval (CI; −1.02, 0.34), P = .33; For fasting plasma glucose, the pooled WMD was −0.27, 95% CI (−1.02, 0.48), P = .48, the pooled WMD for HbA1c% was −0.00, 95% CI (−1.08, 1.08), P = 1.00. CONCLUSIONS: Although certain RCTs showed that TRT improved insulin resistance and glycolipid metabolism when compared with the placebo or untreated control groups, these findings may partly be due to changes in antidiabetic therapy during the course of the study. In the current meta-analysis, analyses showed that TRT did not significantly improve insulin resistance or glycolipid metabolism. Future studies need to be rigorous in design and delivery, and comprehensive descriptions of all aspects of their methods should be included to further enable a more accurate appraisal and interpretation of the results. Yu X, Wei Z, Liu Y, et al. Effects of Testosterone Replacement Therapy on Glycolipid Metabolism Among Hypogonadal Men with T2DM: A Meta-Analysis And System Review Of Randomized Controlled Trials. Sex Med 2021;9:100403. Elsevier 2021-07-20 /pmc/articles/PMC8360908/ /pubmed/34298329 http://dx.doi.org/10.1016/j.esxm.2021.100403 Text en Copyright © 2021 The Authors. Published by Elsevier Inc. on behalf of the International Society for Sexual Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Yu, Xiaowei
Wei, Zhentong
Liu, Yanhong
Zhang, XiaoYuan
Wang, Qun
Effects of Testosterone Replacement Therapy on Glycolipid Metabolism Among Hypogonadal Men withT2DM: A Meta-Analysis And System Review Of Randomized Controlled Trials
title Effects of Testosterone Replacement Therapy on Glycolipid Metabolism Among Hypogonadal Men withT2DM: A Meta-Analysis And System Review Of Randomized Controlled Trials
title_full Effects of Testosterone Replacement Therapy on Glycolipid Metabolism Among Hypogonadal Men withT2DM: A Meta-Analysis And System Review Of Randomized Controlled Trials
title_fullStr Effects of Testosterone Replacement Therapy on Glycolipid Metabolism Among Hypogonadal Men withT2DM: A Meta-Analysis And System Review Of Randomized Controlled Trials
title_full_unstemmed Effects of Testosterone Replacement Therapy on Glycolipid Metabolism Among Hypogonadal Men withT2DM: A Meta-Analysis And System Review Of Randomized Controlled Trials
title_short Effects of Testosterone Replacement Therapy on Glycolipid Metabolism Among Hypogonadal Men withT2DM: A Meta-Analysis And System Review Of Randomized Controlled Trials
title_sort effects of testosterone replacement therapy on glycolipid metabolism among hypogonadal men witht2dm: a meta-analysis and system review of randomized controlled trials
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360908/
https://www.ncbi.nlm.nih.gov/pubmed/34298329
http://dx.doi.org/10.1016/j.esxm.2021.100403
work_keys_str_mv AT yuxiaowei effectsoftestosteronereplacementtherapyonglycolipidmetabolismamonghypogonadalmenwitht2dmametaanalysisandsystemreviewofrandomizedcontrolledtrials
AT weizhentong effectsoftestosteronereplacementtherapyonglycolipidmetabolismamonghypogonadalmenwitht2dmametaanalysisandsystemreviewofrandomizedcontrolledtrials
AT liuyanhong effectsoftestosteronereplacementtherapyonglycolipidmetabolismamonghypogonadalmenwitht2dmametaanalysisandsystemreviewofrandomizedcontrolledtrials
AT zhangxiaoyuan effectsoftestosteronereplacementtherapyonglycolipidmetabolismamonghypogonadalmenwitht2dmametaanalysisandsystemreviewofrandomizedcontrolledtrials
AT wangqun effectsoftestosteronereplacementtherapyonglycolipidmetabolismamonghypogonadalmenwitht2dmametaanalysisandsystemreviewofrandomizedcontrolledtrials